![Ambrx Biopharma Inc. logo](/logos/AMAM.webp)
Ambrx Biopharma Inc.
NYSE:AMAM
Overview | Financials
Company Name | Ambrx Biopharma Inc. |
Symbol | AMAM |
Currency | USD |
Price | 28 |
Market Cap | 1,772,097,600 |
Dividend Yield | 0% |
52-week-range | 6.55 - 28.15 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Daniel J. O'Connor J.D. |
Website | https://ambrx.com |
An error occurred while fetching data.
About Ambrx Biopharma Inc.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD